Mimedx Group Inc’s recently made public that its Chief Commercial Officer Maersk-Moller Kimberly unloaded Company’s shares for reported $14142.0 on Mar 17 ’25. In the deal valued at $8.04 per share,1,759 shares were sold. As a result of this transaction, Maersk-Moller Kimberly now holds 309,077 shares worth roughly $2.12 million.
Then, Hulse William Frank IV sold 54,596 shares, generating $430,762 in total proceeds. Upon selling the shares at $7.89, the General Counsel and CAO now owns 440,178 shares.
Before that, Maersk-Moller Kimberly sold 4,106 shares. Mimedx Group Inc shares valued at $32,396 were divested by the Chief Commercial Officer at a price of $7.89 per share. As a result of the transaction, Maersk-Moller Kimberly now holds 310,836 shares, worth roughly $2.13 million.
Cantor Fitzgerald initiated its Mimedx Group Inc [MDXG] rating to an Overweight in a research note published on July 02, 2024; the price target was $11. A number of analysts have revised their coverage, including Lake Street’s analysts, who began to cover the stock in early March with a ‘”a Buy”‘ rating. Craig Hallum began covering MDXG with “Buy” recommendation on October 27, 2023. Mizuho started covering the stock on October 13, 2022. It rated MDXG as “a Buy”.
Price Performance Review of MDXG
On Tuesday, Mimedx Group Inc [NASDAQ:MDXG] saw its stock fall -3.24% to $6.86. Over the last five days, the stock has lost -8.53%. Mimedx Group Inc shares have fallen nearly -28.69% since the year began. Nevertheless, the stocks have fallen -2.00% over the past one year. While a 52-week high of $10.14 was reached on 01/02/25, a 52-week low of $5.47 was recorded on 04/07/25. SMA at 50 days reached $8.05, while 200 days put it at $7.54.
Levels Of Support And Resistance For MDXG Stock
The 24-hour chart illustrates a support level at 6.66, which if violated will result in even more drops to 6.47. On the upside, there is a resistance level at 7.17. A further resistance level may holdings at 7.48. The Relative Strength Index (RSI) on the 14-day chart is 29.08, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.56, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.44%. Stochastics %K at 16.05% indicates the stock is a buying.
How much short interest is there in Mimedx Group Inc?
A steep rise in short interest was recorded in Mimedx Group Inc stocks on 2025-03-14, growing by 0.43 million shares to a total of 4.15 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 3.72 million shares. There was a rise of 10.43%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 26, 2021 when Northland Capital began covering the stock and recommended ‘”an Outperform”‘ rating along with a $23 price target.
